A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal
Clinical trial NCT03666715 · COMPLETED
Trial details
- NCT number
- NCT03666715
- Sponsor
- Janssen-Cilag Farmaceutica Ltda.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-07
- Primary completion
- 2021-05-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.